193 related articles for article (PubMed ID: 25092141)
1. Comorbidity and performance status in acute myeloid leukemia patients: a nation-wide population-based cohort study.
Østgård LS; Nørgaard JM; Sengeløv H; Severinsen M; Friis LS; Marcher CW; Dufva IH; Nørgaard M
Leukemia; 2015 Mar; 29(3):548-55. PubMed ID: 25092141
[TBL] [Abstract][Full Text] [Related]
2. Comorbidity, age, and mortality among adults treated intensively for acute myeloid leukemia (AML).
Tawfik B; Pardee TS; Isom S; Sliesoraitis S; Winter A; Lawrence J; Powell BL; Klepin HD
J Geriatr Oncol; 2016 Jan; 7(1):24-31. PubMed ID: 26527394
[TBL] [Abstract][Full Text] [Related]
3. Aspects of survival from colorectal cancer in Denmark.
Iversen LH
Dan Med J; 2012 Apr; 59(4):B4428. PubMed ID: 22459726
[TBL] [Abstract][Full Text] [Related]
4. Long-Term Follow-Up and Impact of Comorbidity before Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Relapsed or Refractory Acute Myeloid Leukemia-Lessons Learned from the Prospective BRIDGE Trial.
Middeke JM; Herbst R; Parmentier S; Bug G; Hänel M; Stuhler G; Schäfer-Eckart K; Rösler W; Klein S; Bethge W; Bitz U; Büttner B; Knoth H; Alakel N; Schaich M; Morgner A; Kramer M; Sockel K; von Bonin M; Stölzel F; Platzbecker U; Röllig C; Thiede C; Ehninger G; Bornhäuser M; Schetelig J
Biol Blood Marrow Transplant; 2017 Sep; 23(9):1491-1497. PubMed ID: 28527985
[TBL] [Abstract][Full Text] [Related]
5. Improved outcome in acute myeloid leukemia patients enrolled in clinical trials: A national population-based cohort study of Danish intensive chemotherapy patients.
Østgård LS; Nørgaard M; Sengeløv H; Medeiros BC; Kjeldsen L; Overgaard UM; Severinsen MT; Marcher CW; Jensen MK; Nørgaard JM
Oncotarget; 2016 Nov; 7(44):72044-72056. PubMed ID: 27732947
[TBL] [Abstract][Full Text] [Related]
6. Epidemiology and Clinical Significance of Secondary and Therapy-Related Acute Myeloid Leukemia: A National Population-Based Cohort Study.
Granfeldt Østgård LS; Medeiros BC; Sengeløv H; Nørgaard M; Andersen MK; Dufva IH; Friis LS; Kjeldsen E; Marcher CW; Preiss B; Severinsen M; Nørgaard JM
J Clin Oncol; 2015 Nov; 33(31):3641-9. PubMed ID: 26304885
[TBL] [Abstract][Full Text] [Related]
7. Treatment of elderly patients with acute myeloid leukemia adjusted for performance status and presence of comorbidities: a Polish Adult Leukemia Group study.
Budziszewska BK; Pluta A; Sulek K; Wierzbowska A; Robak T; Giebel S; Holowiecka-Goral A; Sawicki W; Ejduk A; Patkowska E; Manko J; Gajkowska-Kulik J; Piszcz J; Mordak-Domagala M; Madry K; Holowiecki J; Kyrcz-Krzemien S; Nowakowska-Domagala M; Dmoszynska A; Calbecka M; Kloczko J; Wiktor Jędrzejczak W; Lange A; Razny M; Bilinski P; Warzocha K; Lech-Maranda E
Leuk Lymphoma; 2015; 56(8):2331-8. PubMed ID: 25393675
[TBL] [Abstract][Full Text] [Related]
8. Older patients with acute myeloid leukemia benefit from intensive chemotherapy: an update from the Swedish Acute Leukemia Registry.
Juliusson G
Clin Lymphoma Myeloma Leuk; 2011 Jun; 11 Suppl 1():S54-9. PubMed ID: 22035749
[TBL] [Abstract][Full Text] [Related]
9. Age and acute myeloid leukemia: real world data on decision to treat and outcomes from the Swedish Acute Leukemia Registry.
Juliusson G; Antunovic P; Derolf A; Lehmann S; Möllgård L; Stockelberg D; Tidefelt U; Wahlin A; Höglund M
Blood; 2009 Apr; 113(18):4179-87. PubMed ID: 19008455
[TBL] [Abstract][Full Text] [Related]
10. The impact of comorbid disease history on all-cause and cancer-specific mortality in myeloid leukemia and myeloma - a Swedish population-based study.
Mohammadi M; Cao Y; Glimelius I; Bottai M; Eloranta S; Smedby KE
BMC Cancer; 2015 Nov; 15():850. PubMed ID: 26537111
[TBL] [Abstract][Full Text] [Related]
11. Impact of Allogeneic Stem Cell Transplantation in First Complete Remission in Acute Myeloid Leukemia: A National Population-Based Cohort Study.
Østgård LSG; Lund JL; Nørgaard JM; Nørgaard M; Medeiros BC; Nielsen B; Nielsen OJ; Overgaard UM; Kallenbach M; Marcher CW; Riis AH; Sengeløv H
Biol Blood Marrow Transplant; 2018 Feb; 24(2):314-323. PubMed ID: 29051022
[TBL] [Abstract][Full Text] [Related]
12. Characterization and prognostic features of secondary acute myeloid leukemia in a population-based setting: a report from the Swedish Acute Leukemia Registry.
Hulegårdh E; Nilsson C; Lazarevic V; Garelius H; Antunovic P; Rangert Derolf Å; Möllgård L; Uggla B; Wennström L; Wahlin A; Höglund M; Juliusson G; Stockelberg D; Lehmann S
Am J Hematol; 2015 Mar; 90(3):208-14. PubMed ID: 25421221
[TBL] [Abstract][Full Text] [Related]
13. [Complex karyotype is a marker of very poor prognosis in over 70-year-old patients with acute myeloid leukemia and extended types of myelodysplastic syndrome and high comorbidity index].
Gritsaev SV; Martynkevich IS; Abdulkadyrov KM; Ivanova MP; Petrova EV; Zapreeva IM; Tiranova SA; Potikhonova NA
Ter Arkh; 2012; 84(7):16-21. PubMed ID: 23038966
[TBL] [Abstract][Full Text] [Related]
14. Outcomes of Intermediate Risk Karyotype Acute Myeloid Leukemia in First Remission Undergoing Autologous Stem Cell Transplantation Compared With Allogeneic Stem Cell Transplantation and Chemotherapy Consolidation: A Retrospective, Propensity-score Adjusted Analysis.
Limvorapitak W; Barnett MJ; Hogge DE; Forrest DL; Nevill TJ; Narayanan S; Power MM; Nantel SH; Broady R; Song KW; Toze CL; Mourad YA; Sutherland HJ; Gerrie AS; White J; Sanford DS
Clin Lymphoma Myeloma Leuk; 2018 Nov; 18(11):e481-e491. PubMed ID: 30100330
[TBL] [Abstract][Full Text] [Related]
15. Pretreatment risk factors and importance of comorbidity for overall survival, complete remission, and early death in patients with acute myeloid leukemia.
Djunic I; Virijevic M; Novkovic A; Djurasinovic V; Colovic N; Vidovic A; Suvajdzic-Vukovic N; Tomin D
Hematology; 2012 Mar; 17(2):53-8. PubMed ID: 22664041
[TBL] [Abstract][Full Text] [Related]
16. Effects of Education and Income on Treatment and Outcome in Patients With Acute Myeloid Leukemia in a Tax-Supported Health Care System: A National Population-Based Cohort Study.
Østgård LSG; Nørgaard M; Medeiros BC; Friis LS; Schoellkopf C; Severinsen MT; Marcher CW; Nørgaard JM
J Clin Oncol; 2017 Nov; 35(32):3678-3687. PubMed ID: 28892433
[TBL] [Abstract][Full Text] [Related]
17. Acute myeloid leukemia in the real world: why population-based registries are needed.
Juliusson G; Lazarevic V; Hörstedt AS; Hagberg O; Höglund M;
Blood; 2012 Apr; 119(17):3890-9. PubMed ID: 22383796
[TBL] [Abstract][Full Text] [Related]
18. Impact of early remission by induction therapy on allogeneic stem cell transplantation for acute myeloid leukemia with an intermediate-risk karyotype in first complete remission.
Hemmati PG; Terwey TH; Na IK; le Coutre P; Jehn CF; Vuong LG; Dörken B; Arnold R
Eur J Haematol; 2015 May; 94(5):431-8. PubMed ID: 25220715
[TBL] [Abstract][Full Text] [Related]
19. Eighteen-year trends in stroke mortality and the prognostic influence of comorbidity.
Schmidt M; Jacobsen JB; Johnsen SP; Bøtker HE; Sørensen HT
Neurology; 2014 Jan; 82(4):340-50. PubMed ID: 24363134
[TBL] [Abstract][Full Text] [Related]
20. Benefit of allogeneic transplantation in patients age ≥ 60 years with acute myeloid leukemia is limited to those in first complete remission at time of transplant.
Michelis FV; Messner HA; Atenafu EG; Kim DD; Kuruvilla J; Lipton JH; Uhm J; Loach D; Gupta V
Biol Blood Marrow Transplant; 2014 Apr; 20(4):474-9. PubMed ID: 24345422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
